# Porcine Renin (Sus scrofa domesticus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/porcine-renin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Enzyme
**Also Known As:** Sus scrofa domesticus renin, Porcine kidney renin, Pig renin enzyme, Swine renin, Porcine aspartyl protease, Domestic pig renin

## Overview

Porcine renin is a serine protease aspartyl enzyme derived from pig kidneys that catalyzes the conversion of angiotensinogen to angiotensin I, the rate-limiting step of the renin-angiotensin-aldosterone system (RAAS). No human clinical evidence supports its use as a dietary supplement, and species-specific substrate incompatibility significantly limits its physiological relevance in humans.

## Health Benefits

• No established health benefits in humans - no clinical trials exist evaluating porcine renin as a supplement
• May theoretically influence [blood pressure regulation](/ingredients/condition/heart-health) through RAAS activation (animal models only)
• Shows species-specific limitations - poor interaction with human angiotensinogen in xenotransplant studies
• Preclinical rat models used 4-20 mU/kg/hour infusions to study hypertension mechanisms (not therapeutic)
• Currently studied only in research contexts, not as a therapeutic agent

## Mechanism of Action

Porcine renin (EC 3.4.23.15) functions as an aspartyl protease that cleaves the Leu10-Val11 peptide bond of angiotensinogen, releasing the decapeptide angiotensin I. In its native porcine host, this initiates a cascade where angiotensin-converting enzyme (ACE) further processes angiotensin I into the vasoactive angiotensin II, which binds AT1 and AT2 receptors to regulate sodium retention, aldosterone secretion, and [vascular tone](/ingredients/condition/heart-health). However, porcine renin exhibits substantially reduced affinity for human angiotensinogen compared to homologous human renin, due to structural differences in the substrate-binding cleft, rendering this cascade largely inactive when porcine renin is introduced into a human physiological environment.

## Clinical Summary

No published randomized controlled trials, cohort studies, or any human clinical data exist evaluating porcine renin as an oral or supplemental intervention in humans. The foundational research on porcine renin derives from biochemical characterization studies conducted in the 1970s and 1980s, which were primarily used as research tools to understand RAAS pharmacology rather than as therapeutic agents. Animal model studies in rodents and pigs have demonstrated renin's role in [blood pressure](/ingredients/condition/heart-health) elevation and fluid homeostasis, but these findings cannot be extrapolated to human supplementation due to species-specific enzymatic incompatibilities. The overall evidence base for porcine renin as a supplement is effectively nonexistent, placing it in the lowest tier of evidence for any claimed human health benefit.

## Nutritional Profile

Porcine renin is a purified proteolytic enzyme protein (aspartyl protease class) with negligible direct nutritional value as consumed in trace quantities. Molecular weight approximately 37-40 kDa as a glycoprotein. Protein content constitutes ~95-98% of dry mass when in purified form, though administered doses are measured in milli-units (mU), not grams, rendering macronutrient contribution effectively zero (<0.001g protein per therapeutic dose). Contains no meaningful carbohydrate, fat, or fiber content in isolated form. Glycosylation sites carry N-linked oligosaccharide chains (~8-10% of molecular weight by mass) composed of mannose and N-acetylglucosamine residues. As an enzyme derived from porcine renal juxtaglomerular cells, it contains trace zinc and calcium ions as cofactors stabilizing tertiary structure, estimated at <1 µg per administered unit dose. Bioavailability as an intact enzyme: essentially 0% via oral route due to gastric acid denaturation and proteolytic degradation in the GI tract — retains biological activity only when delivered parenterally (IV or subcutaneous). No vitamins, dietary minerals, or fiber content applicable. Biologically active concentration in research settings: 4–20 mU/kg/hour (IV infusion in rat models). Specific activity of purified preparations typically reported at 1–5 Goldblatt units/mg protein. Human substrate affinity (angiotensinogen cleavage) is significantly reduced versus porcine substrate due to amino acid sequence divergence at the cleavage site.

## Dosage & Preparation

No clinically studied dosages exist for porcine renin in humans. Preclinical rat studies used 4-20 mU/kg/hour IV infusions for research purposes only. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Because no human trials exist, a formal safety profile for porcine renin supplementation has not been established, and any risk assessment is purely theoretical. Individuals taking antihypertensive medications that target the RAAS — including ACE inhibitors (e.g., lisinopril), angiotensin receptor blockers (ARBs such as losartan), or direct renin inhibitors (e.g., aliskiren) — should exercise extreme caution, as even theoretical RAAS activation could interfere with these drug mechanisms. People with pork or porcine protein allergies face a clear contraindication due to the pig-derived origin of the enzyme. Pregnant individuals should avoid porcine renin entirely given the critical role of RAAS balance in gestational [blood pressure regulation](/ingredients/condition/heart-health) and the complete absence of safety data.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses exist evaluating porcine renin as a supplement. Available data are limited to preclinical animal models (PMIDs: 758231, 2677138) and xenotransplantation contexts, where porcine renin showed poor interaction with human angiotensinogen, leading to hypotension and graft dysfunction (PMID: 36695679).

## Historical & Cultural Context

No evidence of traditional medicinal use exists for porcine renin in any historical systems including Ayurveda, TCM, or folk medicine. It is a modern biochemical isolate primarily studied in research laboratories since the 1970s for understanding RAAS physiology.

## Synergistic Combinations

Not applicable - no established supplement use

## Frequently Asked Questions

### Does porcine renin work in the human body?

Porcine renin shows very poor catalytic activity against human angiotensinogen due to structural differences in the enzyme's substrate-recognition pocket, specifically around the S1-S3 binding subsites. Studies from the 1980s confirmed that porcine renin has a Km (Michaelis constant) several times higher for human angiotensinogen than for porcine angiotensinogen, meaning it binds and cleaves the human substrate far less efficiently. This species incompatibility makes porcine renin functionally negligible as a supplement in humans.

### What is porcine renin used for in research?

Porcine renin has historically been used as a biochemical research tool to study the renin-angiotensin-aldosterone system (RAAS) because it was one of the first renin enzymes successfully isolated and purified in sufficient quantities from pig kidney juxtaglomerular cells. It was instrumental in the development of the first-generation renin inhibitors, including enalkiren and remikiren, during pharmaceutical research in the 1980s and 1990s. Today, recombinant human renin has largely replaced porcine renin in research applications.

### Can porcine renin lower or raise blood pressure?

In theory, exogenous renin activates the RAAS cascade, producing angiotensin II, which raises blood pressure by promoting vasoconstriction and aldosterone-driven sodium retention — meaning it would be more likely to elevate blood pressure than lower it. However, because porcine renin has poor affinity for human angiotensinogen, this effect is not clinically documented in humans at any tested dose. No human trials have measured blood pressure outcomes following porcine renin supplementation.

### Is porcine renin the same as digestive enzymes like protease?

While porcine renin is technically classified as an aspartyl protease (EC 3.4.23.15), its physiological role is highly specific to the RAAS and is fundamentally different from broad-spectrum digestive proteases such as pepsin, trypsin, or chymotrypsin. Digestive proteases non-specifically cleave dietary proteins in the gastrointestinal tract across many peptide bonds, whereas porcine renin recognizes only one specific substrate — angiotensinogen — and cleaves a single peptide bond (Leu10-Val11). Categorizing it as a general digestive enzyme is therefore a significant oversimplification with no supporting functional evidence.

### Are there any known side effects of taking porcine renin as a supplement?

No formal adverse event data exists for porcine renin supplementation in humans because no clinical trials have been conducted. The most predictable risks include allergic reactions — ranging from mild gastrointestinal upset to anaphylaxis — in individuals with known hypersensitivity to porcine proteins, which affects an estimated 1–2% of the general population. Additionally, theoretical RAAS overstimulation could pose cardiovascular risks, particularly in individuals with hypertension, heart failure, or chronic kidney disease, though this remains unquantified in a human context.

### What does clinical research show about porcine renin as a supplement?

No clinical trials in humans have evaluated porcine renin as a dietary supplement, making it impossible to confirm efficacy or safety in real-world use. Most research on porcine renin is limited to preclinical animal models (primarily rats), which showed it can influence blood pressure through RAAS activation but may not translate reliably to humans due to species-specific differences in enzyme interaction. The lack of human evidence means porcine renin should not be used based on established health claims.

### Is porcine renin safe to take with blood pressure medications?

Porcine renin has potential to interact with blood pressure medications because it theoretically activates the renin-angiotensin-aldosterone system (RAAS), which is the same pathway targeted by ACE inhibitors, ARBs, and other antihypertensive drugs. Taking porcine renin with blood pressure medications could unpredictably alter medication effectiveness or blood pressure control. Anyone taking cardiovascular medications should avoid porcine renin supplements and consult their physician before use.

### Why is porcine renin less effective in humans than in animal studies?

Porcine renin shows poor interaction with human angiotensinogen—the primary substrate it needs to function in the RAAS—according to xenotransplant studies examining species compatibility. This cross-species limitation means the enzyme's activity observed in rat and pig models cannot be reliably replicated in the human body. This fundamental biological incompatibility is a key reason why animal-based research on porcine renin does not support its use as a human supplement.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*